SI1458703T1 - Izokromanske spojine za zdravljenje motenj centralnega živčnega sistema - Google Patents
Izokromanske spojine za zdravljenje motenj centralnega živčnega sistemaInfo
- Publication number
- SI1458703T1 SI1458703T1 SI200230528T SI200230528T SI1458703T1 SI 1458703 T1 SI1458703 T1 SI 1458703T1 SI 200230528 T SI200230528 T SI 200230528T SI 200230528 T SI200230528 T SI 200230528T SI 1458703 T1 SI1458703 T1 SI 1458703T1
- Authority
- SI
- Slovenia
- Prior art keywords
- treatment
- cns disorders
- isochroman compounds
- isochroman
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130339.5A GB0130339D0 (en) | 2001-12-19 | 2001-12-19 | Isochroman compounds |
| EP02793911A EP1458703B1 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of cns disorders |
| PCT/US2002/036148 WO2003053948A1 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1458703T1 true SI1458703T1 (sl) | 2007-08-31 |
Family
ID=9927920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230528T SI1458703T1 (sl) | 2001-12-19 | 2002-12-06 | Izokromanske spojine za zdravljenje motenj centralnega živčnega sistema |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1458703B1 (sl) |
| JP (1) | JP2005516952A (sl) |
| CN (1) | CN1312148C (sl) |
| AR (1) | AR038662A1 (sl) |
| AT (1) | ATE355283T1 (sl) |
| AU (1) | AU2002359378B8 (sl) |
| BR (1) | BR0214859A (sl) |
| CA (1) | CA2469278A1 (sl) |
| CY (1) | CY1106552T1 (sl) |
| DE (1) | DE60218529T2 (sl) |
| DK (1) | DK1458703T3 (sl) |
| ES (1) | ES2280606T3 (sl) |
| GB (1) | GB0130339D0 (sl) |
| MX (1) | MXPA04006085A (sl) |
| PE (1) | PE20030728A1 (sl) |
| PT (1) | PT1458703E (sl) |
| SI (1) | SI1458703T1 (sl) |
| SV (1) | SV2004001441A (sl) |
| TW (1) | TW200301116A (sl) |
| WO (1) | WO2003053948A1 (sl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2000351C2 (nl) | 2005-12-22 | 2007-09-11 | Pfizer Prod Inc | Estrogeen-modulatoren. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247553A (en) * | 1977-10-31 | 1981-01-27 | The Upjohn Company | Methods of treating psychosis |
| EP0737189B1 (en) * | 1993-12-28 | 1999-07-28 | PHARMACIA & UPJOHN COMPANY | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| MX9710260A (es) * | 1995-06-30 | 1998-03-29 | Upjohn Co | Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. |
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
-
2001
- 2001-12-19 GB GBGB0130339.5A patent/GB0130339D0/en not_active Ceased
-
2002
- 2002-11-18 TW TW091133608A patent/TW200301116A/zh unknown
- 2002-12-06 AU AU2002359378A patent/AU2002359378B8/en not_active Ceased
- 2002-12-06 MX MXPA04006085A patent/MXPA04006085A/es active IP Right Grant
- 2002-12-06 SI SI200230528T patent/SI1458703T1/sl unknown
- 2002-12-06 EP EP02793911A patent/EP1458703B1/en not_active Expired - Lifetime
- 2002-12-06 PT PT02793911T patent/PT1458703E/pt unknown
- 2002-12-06 WO PCT/US2002/036148 patent/WO2003053948A1/en active IP Right Grant
- 2002-12-06 CN CNB028281209A patent/CN1312148C/zh not_active Expired - Fee Related
- 2002-12-06 CA CA002469278A patent/CA2469278A1/en not_active Abandoned
- 2002-12-06 DE DE60218529T patent/DE60218529T2/de not_active Expired - Lifetime
- 2002-12-06 ES ES02793911T patent/ES2280606T3/es not_active Expired - Lifetime
- 2002-12-06 AT AT02793911T patent/ATE355283T1/de not_active IP Right Cessation
- 2002-12-06 JP JP2003554664A patent/JP2005516952A/ja not_active Ceased
- 2002-12-06 BR BR0214859-5A patent/BR0214859A/pt not_active IP Right Cessation
- 2002-12-06 DK DK02793911T patent/DK1458703T3/da active
- 2002-12-13 PE PE2002001229A patent/PE20030728A1/es not_active Application Discontinuation
- 2002-12-18 AR ARP020104961A patent/AR038662A1/es unknown
- 2002-12-19 SV SV2002001441A patent/SV2004001441A/es not_active Application Discontinuation
-
2007
- 2007-04-26 CY CY20071100573T patent/CY1106552T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002359378B8 (en) | 2008-09-11 |
| GB0130339D0 (en) | 2002-02-06 |
| CN1620447A (zh) | 2005-05-25 |
| PT1458703E (pt) | 2007-05-31 |
| BR0214859A (pt) | 2004-11-03 |
| EP1458703A1 (en) | 2004-09-22 |
| JP2005516952A (ja) | 2005-06-09 |
| ATE355283T1 (de) | 2006-03-15 |
| EP1458703B1 (en) | 2007-02-28 |
| CY1106552T1 (el) | 2012-01-25 |
| AU2002359378B2 (en) | 2008-08-21 |
| SV2004001441A (es) | 2004-05-07 |
| AR038662A1 (es) | 2005-01-26 |
| DE60218529T2 (de) | 2007-11-22 |
| AU2002359378A1 (en) | 2003-07-09 |
| CA2469278A1 (en) | 2003-07-03 |
| ES2280606T3 (es) | 2007-09-16 |
| DK1458703T3 (da) | 2007-06-11 |
| DE60218529D1 (de) | 2007-04-12 |
| PE20030728A1 (es) | 2003-08-29 |
| WO2003053948A1 (en) | 2003-07-03 |
| TW200301116A (en) | 2003-07-01 |
| MXPA04006085A (es) | 2004-09-27 |
| CN1312148C (zh) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1443929A4 (en) | TREATMENT OF CNS DISTURBANCES WITH CNS TARGET MODULATORS | |
| IL209842A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| PL372425A1 (en) | Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders | |
| ZA200401004B (en) | Combination for the treatment of inflammatory disorders | |
| IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
| AU8187701A (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| AU2002356525A1 (en) | Substituted amines for the treatment of neurological disorders | |
| HUP0400024A3 (en) | Combination for treatment of neoplastic diseases | |
| HUP0401805A3 (en) | Compounds suitable for treating pulmonary diseases | |
| HUP0302530A3 (en) | Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid | |
| EP1461030A4 (en) | AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA | |
| AU7388101A (en) | Indole derivatives useful for the treatment of cns disorders | |
| GB0123145D0 (en) | Apparatus for the purification of water | |
| AU8339301A (en) | Compounds for the treatment of addictive disorders | |
| IL162053A0 (en) | Method for the treatment of bone disorders | |
| SI1468686T1 (sl) | S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj | |
| AU8173801A (en) | Indole derivatives useful for the treatment of cns disorders | |
| SI1458703T1 (sl) | Izokromanske spojine za zdravljenje motenj centralnega živčnega sistema | |
| AU2003239967A1 (en) | Compound for the treatment of cns disorders | |
| IL175279A0 (en) | Beta-lactams for treatment of cns disorders | |
| AU2003243214A1 (en) | Salts of bis-arylsulfones for the treatment of cns disorders | |
| IL158383A0 (en) | Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops | |
| AU2002256401A1 (en) | Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders | |
| PL343596A1 (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders |